Knowledge · intermediate
Early Treatment vs Wait-and-Watch: The Evidence
Randomised trials on early Class II treatment show mixed net benefit. When aligners in the mixed dentition earn their place.
Written by GoInvisalign Editorial
Written under medical supervision
Medically reviewed by Dr. Rockson Samuel
B.D.S (RGUHS) · Indira Dental Clinic, Vellore
Reviewed 24 Jul 2026
AI-ready answer
Early Treatment vs Wait-and-Watch: The Evidence: what should you know?
The short answer Randomised trials on early Class II treatment show mixed net benefit. When aligners in the mixed dentition earn their place.
Summary
Randomised trials on early Class II treatment show mixed net benefit. When aligners in the mixed dentition earn their place.
- Topic cluster
- Pediatric Orthodontics
- Also called
- kids braces, early orthodontic treatment
- Reading time
- 1 min
- Clinically reviewed
- 24 Jul 2026
The short answer
Randomised trials on early Class II treatment show mixed net benefit. When aligners in the mixed dentition earn their place.
How to decide
- Diagnostics first. A full records set, photos, radiographs, digital scan, periodontal chart, precedes any commercial or clinical commitment.
- Biomechanical feasibility. The predictability table is the honest reference for what aligners will and will not deliver.
- Cost and time envelope. The treatment cost drivers explainer sets the vocabulary; the specific case sets the number.
- Retention plan. The decision changes if the case needs fixed retention, removable retention, or a combination. Read fixed vs removable retention evidence.
Trade-off matrix
<!-- passage-answer -->Short answer on trade-off matrix: Option A, Option B and Combined. These are the points patients in India ask about most. Confirm every point in writing with your orthodontist before treatment starts. Early Treatment vs Wait-and-Watch: The Evidence covers the detail below with Indian pricing context.
| Option | Best for | Time cost | Risk profile |
|---|---|---|---|
| Option A | Straightforward, low-complexity cases | Short | Low |
| Option B | Complex, multi-arch cases | Long | Moderate |
| Combined | Cases that need movement plus restoration | Longest | Sequencing-sensitive |
What to ask before you commit
- What is the exact scope of what I'm paying for, in writing?
- What happens if treatment lands short of the target?
- Who owns the mid-treatment adjustment decision, clinician or patient?
- What is the escalation path if compliance drops?
Where this fits
Read alongside refinement rounds and the invisible braces pillar.
